DiscoverI AM BIOEditing Cells Within the Body—a New CRISPR Frontier
Editing Cells Within the Body—a New CRISPR Frontier

Editing Cells Within the Body—a New CRISPR Frontier

Update: 2024-04-23
Share

Description

With its potential to expand the horizons of what’s possible for patients, CRISPR is the new darling of biotech. Reaching an important milestone in 2023 with the FDA approval of a sickle cell treatment using CRISPR, the technology is poised to break new barriers for treating patients in the near future. In this episode we talk with two companies working together on the next generation of CRISPR: editing cells within the body.  We discuss the progress and the challenge in making this breakthrough a reality. 

Follow us on LinkedIn, X, Facebook and Instagram

Visit us at https://www.bio.org/

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Editing Cells Within the Body—a New CRISPR Frontier

Editing Cells Within the Body—a New CRISPR Frontier

Christos Kyratsous PhD Senior Vice President Research Regeneron Pharmaceuticals, John Leonard MD President and Chief Executive Officer Intellia Therapeutics